|
14 April 2003
Auckland, April 14, 2003 – Genesis Research and Development Corporation Limited (NZSE/ASX: GEN) today announced the results of the voting conducted at the Annual Meeting held on 11 April. A poll was held on five resolutions for election of directors. Mr David Irving, Chairman, was re-elected and Dr Douglas Wilson, Mr John Palmer and Mr Allan Freeth were elected. Mr Herman Rockefeller, a director of Genesis Research since its establishment in 1993, was not re-elected. The Financial Statements and Annual Report and a new Constitution were also approved. The motion to increase directors’ fees was withdrawn by the Board. About Genesis Founded in 1994, Genesis is a New Zealand-based biotechnology company committed to the building of a broad genomic platform for the development of innovative products in health and plant biotechnology. Genesis partners with industry leaders to develop products which have global market potential through the mining of its extensive microbe, plant and mammalian EST databases. The Health Division has three programmes in human clinical development for the treatment of psoriasis, atopic dermatitis (eczema) and asthma, with additional programmes for cancer and other indications in pre-clinical development. The patented BioStore solutions for storage of tissues and living cells are also in pre-clinical development. Collaborations are maintained with Amgen Inc. (NASDAQ: AMGN), Corixa Corporation (NASDAQ: CRXA), SR Pharma (LSE: SPA), and Jurox Pty Ltd. The Plant division has research collaborations with ArborGen, Wrightson (NZSE: WRI), HortResearch, AgResearch, and Landcare. Genesis is also undertaking significant unpartnered research programmes in novel plant hormones. The company has an extensive health and plant patent portfolio. For more information, please visit www.genesis.co.nz Media contacts: Dr James D Watson, Chief Executive, Genesis Research and Development Corporation Limited, +64 9 373 5600 Allan Botica, Botica Butler Raudon Partners, +64 9 303 3862, +64 21 400 500, allanb@botica.co.nz |